A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-ThalassemiaMaria Domenica Cappellini, Antonio Piga, Vip Viprakasit et al.|New England Journal of Medicine|2020Cited by 320
National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortalityIoannis Papassotiriou, Ersi Voskaridou, Antonis Kattamis et al.|Annals of Hematology|2018Cited by 72
Beta-thalassemia: renal complications and mechanisms: a narrative reviewChristos Demosthenous, Pantelis Sarafidis, Efthymia Vlachaki et al.|Hematology|2019Cited by 62
The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell (RBC) TransfusionsMaria Domenica Cappellini, Antonio Piga, Vip Viprakasit et al.|Blood|2018Cited by 14
β-Thalassemia and renal complications. A narrative review of pathophysiologic mechanismsChristos Demosthenous, Efthymia Vlachaki, Perla Eleftheriou et al.|Integrative Molecular Medicine|2018Cited by 10